Table 1 The Child-Pugh class level, HBV DNA level and full blood test analysis corresponding to pembrolizumab and lenvatinib combination therapy
Date | ALB(g/l) | HE | PT | INR | Ascites | T-BIL | Score | HBV-DNA | WBC(10^9/L) | GR(10^9/L) | HGB(g/L) | PLT(10^9/L) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
17.11.27 | 30.4 | N | 15.3 | 1.35 | Y | 16.4 | 8 | 2370 | 1.3 | 0.58 | 112 | 42 |
18.2.7 | 31.6 | N | 15.4 | 1.3 | N | 17.3 | 7 | <30 | 1.45 | 0.81 | 118 | 43 |
18.3.2 | 33.0 | N | 15.6 | 1.31 | N | 23.6 | 7 | <30 | 1.89 | 0.99 | 126 | 48 |
18.4.8 | 25 | N | 20.4 | 1.73 | N | 32.7 | 10 | 38.7 | 1.62 | 0.67 | 127 | 21 |
18.6.11 | 26 | N | 16.6 | 1.4 | N | 31.1 | 7 | <20 | 1.21 | 0.58 | 110 | 23 |
18.7.9 | 29.7 | N | 16.5 | 1.39 | N | 25.3 | 7 | / | 1.26 | 0.71 | 113 | 34 |
18.7.31 | 30.3 | N | 16.6 | 1.4 | N | 30.8 | 7 | / | 1.42 | 0.72 | 120 | 21 |
18.8.22 | 29.2 | N | 16.2 | 1.36 | N | 20.5 | 7 | <20 | 0.9 | 0.42 | 106 | 25 |
18.11.9 | 31.8 | N | 15.4 | 1.29 | N | 21.6 | 7 | <20 | 1.33 | 0.69 | 117 | 27 |